Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM
Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)
Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.
Tuesday, December 6, 2016 | 9:00 AM - 5:00 PM
Speakers: Katerina Akassoglou (University of California San Francisco), Robert Dempsey (University of Wisconsin), Paula Grammas (University of Rhode Island), Steven Greenberg (Harvard Medical School), Jaime Grutzendler (Yale University), Costantino Iadecola (Weill Cornell Medical College), Jeffrey Iliff (Oregon Health & Science University), Berislav V. Zlokovic (University of Southern California)
This symposium will highlight basic research and clinical science elucidating the mechanisms underlying vascular contributions to cognitive impairment and dementia (VCID).
Wednesday, July 13, 2016 | 9:00 AM - 5:00 PM
Keynote Speaker: David Bartel (Whitehead/MIT/HHMI)
Speakers: Paul Grint (Regulus Therapeutics), David S Hong (The University of Texas MD Anderson Cancer Center ), Daniel J Siegwart (University of Texas Southwestern Medical Center), Frank Slack (BIDMC Cancer Center/Harvard Medical School), James W Welsh (The University of Texas MD Anderson Cancer Center)
miRNAs play critical roles in regulating gene expression. This symposium will present up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Tuesday, June 21, 2016 | 8:30 AM - 5:00 PM
Keynote Speaker: Sharon Inouye (Harvard Medical School)
This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.
April 13 - 14, 2016
Keynote Speakers: Richard Hodes (National Institute on Aging and National Institutes of Health), Felipe Sierra (National Institute on Aging and National Institutes of Health), Steven Austad (University of Alabama at Birmingham), and Elissa Epel (University of California, San Francisco)
Explore how chronic diseases — specifically HIV/AIDS, diabetes, and cancer — can affect the seven mechanistic pillars of aging.
Edited by Annals of the New York Academy of Sciences
This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.
Organizers: Thomas F. Franke (NYU School of Medicine), Eric Nestler (Icahn School of Medicine at Mount Sinai), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing explores work to map the brain and define its circuitry.
Edited by Sonia Sequeira
(Memorial Sloan Kettering Cancer Center)
This Annals special issue presents advances in interdisciplinary research exploring the neural correlates and clinical applications of the practice of meditation.
Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.